Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Thyroid Neoplasms 1Thymoma 1Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Neoplasms 1Mouth Neoplasms 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Carcinoma, Lobular 1

Interventions

Fulvestrant 128Trastuzumab 118Paclitaxel 114Letrozole 108pembrolizumab 80pertuzumab 76palbociclib 76Capecitabine 74Anastrozole 73Cyclophosphamide 70Carboplatin 68abemaciclib 66exemestane 64Tamoxifen 62ribociclib 61trastuzumab deruxtecan 56Surveys and Questionnaires 50Specimen Handling 50Radiotherapy 50Docetaxel 49Magnetic Resonance Spectroscopy 47Blood Specimen Collection 42olaparib 40Standard of Care 36sacituzumab govitecan 32Biopsy 32130-nm albumin-bound paclitaxel 32Exercise 30Doxorubicin 30eribulin 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Radiotherapy, Adjuvant × 1 year × Clear all
NCT06897488 2026-05-15

EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

M.D. Anderson Cancer Center

Phase 2 Recruiting
300 enrolled
Breast

Breast Neoplasms

NCT06914440 2025-07-15

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

Xijing Hospital

Phase 2 Recruiting
27 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡